4.6 Article

Iron Concentration Does Not Differ in Blood but Tends to Decrease in Cerebrospinal Fluid in Parkinson's Disease

期刊

FRONTIERS IN NEUROSCIENCE
卷 13, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fnins.2019.00939

关键词

iron; Parkinson's disease; blood; cerebrospinal fluid; meta-analysis

资金

  1. National Foundation of Natural Science of China [81701377]
  2. Shandong Provincial Natural Science Foundation, China [ZR2016HM11]
  3. Key Research and Development Program of Shandong Province [2016GSF201053]
  4. Qingdao Municipal Science and Technology Project [16-2-2-nsh]
  5. Taishan Scholars Construction Project

向作者/读者索取更多资源

Background: Iron accumulation in the substantia nigra in PD patients was acknowledged, but the studies on alteration of iron levels in blood and cerebrospinal fluids (CSF) reported inconsistent results. Objective: To determinate the alterations of blood and CSF levels of iron in PD patients, a case-control study and a meta-analysis both in blood and CSF were conducted. Methods: In the case-control study, 43 PD patients and 33 controls were recruited to test iron metabolism, 15 normal and 12 PD patients donated CSF. Levels in iron were quantified by inductively coupled atomic emission spectrometry. Iron metabolism was analyzed by routine blood tests. In the meta-analysis, a comprehensive literature search was performed on relevant studies published from Jan 1980 to Dec 2018 in PubMed, Web of Science and EMBASE databases. The pooled standard mean difference (SMD) with random effects model was selected to estimate the association between iron levels and PD. Results: In the case-control study, the iron level in serum in the controls and PD patients were 110.00 +/- 48.75 m g/dl and 107.21 +/- 34.25 m g/dl, respectively, no significant difference was found between them (p = 0.850), with a small effect size (Cohen's d: 0.12; 95% CI: 0.08-0.17). Ferritin level in PD patients was lower than controls (p = 0.014). The CSF levels of iron in control and the PD patients were 20.14 +/- 3.35 ng/dl and 16.26 +/- 4.82 ng/dl, respectively. CSF levels of iron were lower in PD compared with that of controls (p = 0.021), with a moderate effect size (Cohen's d: 0.51; 95% CI: 0.43-0.65). In the meta-analysis, 22 eligible studies and a total of 3607 participants were identified. Blood levels of iron did not differ significant between PD patients and the controls [SMD (95% CI): -0.03 (-0.30, 0.24)], but CSF iron levels tended to be lower in PD patients compared with that in the controls [SMD (95% CI): -0.33 (0.65, 0.00)]. Conclusion: Iron homeostasis may be disturbed in CSF, but not in the peripheral blood in PD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据